Avid Bioservices Revenue, Growth & Competitor Profile

DBA PEREGRINE PHARMACEUTICALS

Company Profile & Annual Report for Avid Bioservices

Access the complete profile.

Avid Bioservices Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	14191 Myford Rd Tustin, CA 92780

Avid Bioservices's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Avid Bioservices's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Avid Bioservices is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Avid Bioservices is a publicly traded company on using the ticker symbol PPHM. Detailed information on company financials and operating reports can be found here: : PPHM

Avid Bioservices Annual Revenue and Growth Rate

Avid Bioservices	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Avid Bioservices's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Avid Bioservices is developing and marketing. Avid Bioservices doesn't have any recent trademark applications, indicating Avid Bioservices is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AVID BIOSERVICES WHERE COLLABORATION, QUALITY, AND RELIABILITY MEET. Contract manufacturing services of biopharmaceuticals, namely, antibodies and recombinant proteins utilizing mammalian cell culture, to the order and/or specification of others	07/21/2022
TALCEPTRX Pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer, infectious diseases and diseases and disorders in which phosphatidylserine (PS) is a marker	09/28/2015
TALRIMZA Pharmaceutical preparations, namely, antibodies for the treatment and diagnosis of cancer, infectious diseases and diseases and disorders in which phosphatidylserine (PS) is a marker	09/28/2015

See all trademarks and details in the Full Report.

Market Share of Avid Bioservices's Largest Competitors

A competitive analysis shows these companies are in the same general field as Avid Bioservices, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Avid Bioservices. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AVID BIOSERVICES	Tustin, CA	100
CODAN US	Santa Ana, CA	15
SG HOMECARE	Tustin, CA	10
ACKLEY METAL PRODUCTS	Santa Ana, CA	6
FLATHERS PRECISION	Santa Ana, CA	4
CASCADE OPTICAL COATINGS INCORPORA TED DBA CASCADE OPTICAL	Santa Ana, CA	4

Future Competition: Avid Bioservices's Fastest Growing Competitors

These companies are in the same general field as Avid Bioservices and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)